Emerging Concepts Targeting Immune Checkpoints in Cancer and Autoimmunity

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Specialties, Oncology
Cover of the book Emerging Concepts Targeting Immune Checkpoints in Cancer and Autoimmunity by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319689296
Publisher: Springer International Publishing Publication: November 25, 2017
Imprint: Springer Language: English
Author:
ISBN: 9783319689296
Publisher: Springer International Publishing
Publication: November 25, 2017
Imprint: Springer
Language: English

This volume reviews the current state of research on immune checkpoints and offers novel concepts. It discusses the two most important immune checkpoints: T lymphocyte-associated antigen-4 (CTLA-4) and programmed cell death-1 (PD-1). It shows that antagonistic antibodies against these two molecules are highly effective in the treatment of various cancers and that PD-1 and CTLA-4 have been linked to the suppression of T-cell receptor signaling and co-stimulatory molecules. Further, the volume examines other agents, a number of cells, receptors and signaling molecules, that are also involved in the regulation of T-cell activation and extends the concept of immune checkpoints to “molecules and cells that negatively regulate T-cell activation”. Playing essential roles in immune homeostasis, they could offer new targets for cancer immunotherapy, and for the therapy of autoimmune diseases.

Written by internationally respected scientists, this book will appeal to basic scientists, clinicians, drug development researchers, and advanced students alike.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This volume reviews the current state of research on immune checkpoints and offers novel concepts. It discusses the two most important immune checkpoints: T lymphocyte-associated antigen-4 (CTLA-4) and programmed cell death-1 (PD-1). It shows that antagonistic antibodies against these two molecules are highly effective in the treatment of various cancers and that PD-1 and CTLA-4 have been linked to the suppression of T-cell receptor signaling and co-stimulatory molecules. Further, the volume examines other agents, a number of cells, receptors and signaling molecules, that are also involved in the regulation of T-cell activation and extends the concept of immune checkpoints to “molecules and cells that negatively regulate T-cell activation”. Playing essential roles in immune homeostasis, they could offer new targets for cancer immunotherapy, and for the therapy of autoimmune diseases.

Written by internationally respected scientists, this book will appeal to basic scientists, clinicians, drug development researchers, and advanced students alike.

More books from Springer International Publishing

Cover of the book Pedestrian Fall Safety Assessments by
Cover of the book Stigma and Prejudice by
Cover of the book Digital Soil Morphometrics by
Cover of the book Grasp Interaction with Tablets by
Cover of the book Cognitive Resource Management for Heterogeneous Cellular Networks by
Cover of the book The Chemical Bond III by
Cover of the book Autonomic Nervous System by
Cover of the book India's Journey Towards Sustainable Population by
Cover of the book The European Union and the Eurozone under Stress by
Cover of the book The Greek Debt Crisis by
Cover of the book The Soils of Iran by
Cover of the book A Guide to Hubble Space Telescope Objects by
Cover of the book STEM and ICT Education in Intelligent Environments by
Cover of the book Innovative Research Methodologies in Management by
Cover of the book Grapes and Health by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy